Globus Medical (GMED)

• Market cap: $11.1B
• 1 day: -1.06%
• 5 days: -1.49%
• 1 month: -2.47%
• 3 months: 16.93%
• 6 months: 20.25%
• Year to date: 53.93%
• 1 year: 53.93%
• 5 years: 37.65%
• 10 years: 244.98%
• Sector: Healthcare
• Industry: Surgical & Medical Instruments & Apparatus

About: Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States.

Employees: 5,000

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

300% more call options, than puts

Call options by funds: $13.5M | Put options by funds: $3.38M

1% less funds holding

Funds holding: 446 [Q2] → 442 (-4) [Q3]

2% less capital invested

Capital invested by funds: $7.95B [Q2] → $7.79B (-$162M) [Q3]

7% less first-time investments, than exits

New positions opened: 54 | Existing positions closed: 58

6.72% less ownership

Funds ownership: 103.1% [Q2] → 96.39% (-6.72%) [Q3]

17% less repeat investments, than reductions

Existing positions increased: 144 | Existing positions reduced: 174

18% less funds holding in top 10

Funds holding in top 10: 22 [Q2] → 18 (-4) [Q3]

Research analyst outlook

10 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $80 2% downside
• Avg. target: $95 16% upside
• High target: $115 41% upside

10 analyst ratings

• positive: 8 80%
• neutral: 1 10%
• negative: 1 10%

Truist Securities Richard Newitter 71% 1-year accuracy 30 / 42 met price target	10% upside $90	Hold Maintained	18 Dec 2024
Roth MKM Jason Wittes 65% 1-year accuracy 13 / 20 met price target	41% upside $115	Buy Maintained	17 Dec 2024
BTIG Ryan Zimmerman 64% 1-year accuracy 30 / 47 met price target	11% upside $91	Buy Maintained	12 Dec 2024
Wells Fargo Vik Chopra 60% 1-year accuracy 6 / 10 met price target	16% upside $95	Overweight Maintained	11 Dec 2024
Canaccord Genuity William Plovanic 59% 1-year accuracy 27 / 46 met price target	12% upside $92	Buy Maintained	9 Dec 2024